Study guide
13.2 ELISA, Immunofluorescence, Solid Phase & Column Agglutination
Specialist in Blood Banking, SBB ASCP
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 Current Exam Facts 1.2 Eligibility Routes & Credential Maintenance 1.3 Study Strategy for SBB
2 Donors & Collection
2.1 Donor Qualification 2.2 Collection Methods & Adverse Reactions 2.3 Special Donations
3 Processing, Storage & Component QC
3.1 Processing, Testing & Labeling 3.2 Storage, Transport & Expiration 3.3 Blood Component Quality Control
4 Red Cell & Modified Components
4.1 Whole Blood & Red Blood Cells 4.2 Leukocyte-Reduced, Washed, Frozen & Rejuvenated RBCs 4.3 Irradiated Components 4.4 Granulocytes
5 Platelets, Plasma & Cellular Products
5.1 Platelets 5.2 Plasma & Cryoprecipitated AHF 5.3 Apheresis Products & Fractionation Products 5.4 Hematopoietic Progenitors
6 Genetics, ABO & Rh
6.1 Blood Group Genetics & Molecular Inheritance 6.2 ABO & Lewis Systems 6.3 Rh System 6.4 MNS, P1PK/Globoside & Ii
7 Other Blood Groups & Role in Transfusion
7.1 Kell, Kidd, Duffy & Lutheran 7.2 Other Systems & High/Low-Prevalence Antigens 7.3 HLA, Platelet-Specific & Granulocyte Antigens 7.4 Immunogenicity & Antigen Prevalence
8 Immunology Foundations
8.1 Immune Response 8.2 Immunoglobulins 8.3 Antigen-Antibody Interactions 8.4 Complement
9 Physiology, Hemostasis & HDFN
9.1 Physiology of Blood 9.2 Hemostasis and Coagulation 9.3 HDFN Pathophysiology & Detection 9.4 HDFN Treatment & Prevention
10 Cytopenias & Transplantation
10.1 Immune & Nonimmune Anemia 10.2 Thrombocytopenia & Neutropenia 10.3 Solid Organ Transplantation Support 10.4 Hematopoietic Progenitor Cell Transplantation
11 Routine Serologic Testing
11.1 Blood Grouping Tests 11.2 Antibody Detection & Crossmatch 11.3 Antibody Identification & Clinical Significance 11.4 Direct Antiglobulin Testing & Reagents
12 Special Serologic Methods
12.1 Enzymes, Enhancement Media & Lectins 12.2 Adsorptions, Elutions & Titrations 12.3 Cell Separations, Neutralization & Thiol Reagents 12.4 Chloroquine Diphosphate & EDTA-Glycine Acid
13 Molecular Platforms & Serologic QA
13.1 Molecular Blood Group Techniques 13.2 ELISA, Immunofluorescence, Solid Phase & Column Agglutination 13.3 Serologic Quality Assurance
14 Indications, Component Therapy & PBM
14.1 Indications for Transfusion 14.2 Component Therapy 14.3 Blood Administration & Patient Blood Management
15 Adverse Effects of Transfusion
15.1 Immunologic Transfusion Reactions 15.2 Nonimmunologic Reactions 15.3 Transfusion-Transmitted Diseases
16 Apheresis & Extracorporeal Circulation
16.1 Therapeutic Apheresis 16.2 Extracorporeal Circulation
17 Quality, Safety, Math & Instrumentation
17.1 Quality Assessment & Troubleshooting 17.2 Laboratory Safety 17.3 Laboratory Mathematics 17.4 Instrumentation
18 Laboratory Administration (SBB Only)
18.1 Financial Management 18.2 Operations & Information Technology 18.3 Personnel, Education & Training 18.4 Quality Management, Risk & Tissue Management
13.2 ELISA, Immunofluorescence, Solid Phase & Column Agglutination
Key Takeaways Explain This Topic AI
In solid-phase red cell adherence testing, a positive result is a diffuse cell layer across the well, while a negative result is a compact button - the reverse of tube-testing logic
Column (gel) agglutination technology traps agglutinates by size in a gel matrix, producing standardized, photographable grading from a small sample volume
Flow cytometry with fluorescent anti-D is the reference method for quantifying fetomaternal hemorrhage to dose RhIG precisely
Rouleaux, mixed-field reactions, prozone, and fibrin strands are the four classic causes of false-appearing agglutination across non-tube platforms
- ELISA reports a calculated optical-density ratio against a cutoff, not a graded visual agglutination reaction
- Last updated: July 2026
13.2 ELISA, Immunofluorescence, Solid Phase & Column Agglutination
Quick Answer: ASCP outline IV.C.8, 12-14 groups four non-tube methods that the SBB exam tests primarily on how a positive result looks different from a negative one - because each platform reverses or changes the visual logic technologists learned with manual tube testing. Knowing the underlying principle of each method, and its characteristic interpretation traps, is worth more on exam day than memorizing manufacturer names.
Enzyme-Linked Immunosorbent Assay (ELISA)
ELISA is a microplate-based immunoassay in which antigen or antibody is bound (adsorbed) to the well surface, the patient specimen is added, and an enzyme-labeled secondary antibody produces a colorimetric or chemiluminescent signal proportional to the amount of bound target. In transfusion medicine, ELISA's biggest footprint is in donor infectious disease screening (HIV, hepatitis, HTLV, and other markers), where its high sensitivity and suitability for automated, high-throughput testing outweigh its longer turnaround time compared with rapid or immediate-spin methods. ELISA is also used for platelet and HLA antibody screening panels. A key exam distinction: ELISA reports a quantitative optical density value compared against a cutoff, not a graded agglutination reaction - "positive" or "negative" is a calculated ratio, not a visual judgment call.
Immunofluorescence
Immunofluorescence techniques use a fluorochrome-labeled antihuman globulin or antigen-specific reagent, read by fluorescence microscopy or flow cytometry rather than by visible agglutination. Two blood bank applications matter most for the exam:
Direct antiglobulin test (DAT) confirmation and characterization - fluorescent anti-IgG/anti-C3d reagents can help resolve weakly positive or mixed-field DATs that are ambiguous by traditional tube or gel methods.
Flow cytometric quantification - flow cytometry using fluorescent anti-D is the reference method for quantifying fetomaternal hemorrhage (FMH) when a rosette test is positive or borderline, replacing the older acid-elution Kleihauer-Betke smear for precise dosing of RhIG in D-negative mothers. Flow cytometry is also used to quantify weak antigen expression that is difficult to grade reliably by eye (for example, distinguishing a true weak-antigen population from a mixed-field population after transfusion or transplant).
Solid Phase Red Cell Adherence (SPRCA)
In solid-phase testing, reagent antigen (or antibody) is immobilized on the bottom of a microplate well. After incubation and washing, indicator red blood cells are added and the plate is centrifuged. This is the platform's signature interpretation trap: a positive reaction produces a diffuse monolayer of indicator cells adhering evenly across the entire well surface, while a negative reaction produces a tightly packed red cell button at the bottom of the well - the visual logic is the reverse of what technologists expect from tube agglutination, where clumping (not a button) signals a positive result. Solid-phase methods are commonly used for antibody screening, crossmatching, and platelet antibody detection, and are well suited to automation.
Column (Gel) Agglutination Technology
Column agglutination microtubes contain a dextran-acrylamide gel matrix, either neutral or impregnated with reagents such as anti-IgG (for indirect antiglobulin testing) or specific antisera. After a low-speed centrifugation step, agglutinates are physically trapped within the gel based on their size: strong agglutinates remain at the top of the column (graded up to 4+), progressively smaller aggregates are trapped at intermediate levels, and unagglutinated cells pass completely through the gel to form a pellet at the bottom (negative). This produces a standardized, objective, and photographable gradient that reduces technologist-to-technologist variability compared with manual tube shake-and-read technique, and it requires very small sample volumes.
Side-by-Side Comparison
- Method Positive Signal Negative Signal Key Exam Trap
- ELISA Optical density above cutoff OD below cutoff Reported as a calculated ratio, not a graded reaction
Immunofluorescence/Flow Fluorescent signal above threshold on cells/population No significant fluorescent shift Best method for precise FMH quantification, not routine screening
Solid phase (SPRCA) Diffuse adherence layer across the well Compact button at well bottom Positive = spread out; negative = pellet (opposite of tube logic)
Column/gel agglutination Agglutinates trapped at or above mid-column Cells pass through to form a bottom pellet Rouleaux and fibrin can mimic trapped agglutinates
Interpretation Traps Across All Platforms
Rouleaux formation - stacked-coin red cell aggregates from abnormal protein ratios (e.g., multiple myeloma, elevated fibrinogen) can look like weak agglutination in gel columns or tubes. A saline replacement/auto-control technique disperses true rouleaux but leaves true agglutination intact, and is the standard resolution step before finalizing a result.
Mixed-field reactions - two red cell populations (recent transfusion, bone marrow/stem cell transplant chimerism, or an A subgroup with an A antibody) create a pattern of small agglutinates scattered among free cells; this looks different from a uniform weak positive and should prompt a transfusion/transplant history review before interpretation.
Prozone effect - very high antibody titer can cause a falsely weak or negative reaction due to antigen excess; diluting the serum can unmask a stronger true reaction.
Fibrin strands - incompletely clotted serum samples can trap cells in a way that mimics agglutination or gel trapping; a properly clotted, centrifuged sample avoids this artifact.
Section Takeaways
Solid-phase testing reverses the tube-testing visual rule: positive spreads out, negative forms a pellet.
Gel column technology traps agglutinates by size, giving standardized, reproducible grading with small sample volumes.
Flow cytometry/immunofluorescence is the reference method for quantifying fetomaternal hemorrhage and resolving ambiguous DAT results.
Rouleaux, mixed-field populations, prozone, and fibrin are the recurring "fake positive/fake negative" traps across all non-tube platforms.